Supply https://www.uu.se/en/information/2024/2024-03-15-ricerca-innovativa-in-terapia-psychedelica
PsyPal, because the examine is known as, is coordinated by the Medical Heart of the College of Groningen, Netherlands, and is the primary of its form to obtain EU funding. Uppsala College is without doubt one of the establishments collaborating within the examine.
Inna Feldman, Docent of Well being Economics within the Division of Public Well being and Care Sciences, will contribute her experience to the venture.
“That is the primary examine in Europe to discover such a therapy for sufferers on the finish of life. The purpose is to find out whether or not sufferers with Persistent Obstructive Pulmonary Dysfunction (COPD), MS, ALS and atypical Parkinson's can obtain a greater high quality of life with psilocybin remedy. It's about serving to sufferers stay in addition to potential, for so long as potential,” says Inna Feldman.
Learn extra https://www.uu.se/en/information/2024/2024-03-15-groundbreaking-research-in-psychedelic-therapy
